CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 50.30
+1.54 (3.16%)
Aug 15, 2025, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 17.19 billion as of August 15, 2025. Its market cap has increased by 138.54% in one year.
Market Cap
17.19B
Enterprise Value
16.01B
Revenue
931.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.30
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 17.19B, an increase of 127.10%. That is a compound annual growth rate of 13.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| JD Health International | 179.05B |
| Innovent Biologics | 162.71B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |